These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32807633)

  • 1. Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.
    Boscari F; Morieri ML; Amato AML; Vallone V; Uliana A; Baritussio A; Vitturi N; Cipponeri E; Cavallin F; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1813-1819. PubMed ID: 32807633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools.
    Helleputte S; Van Bortel L; Verbeke F; Op 't Roodt J; Calders P; Lapauw B; De Backer T
    Cardiovasc Diabetol; 2022 Jun; 21(1):97. PubMed ID: 35681143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.
    Tecce N; Masulli M; Lupoli R; Della Pepa G; Bozzetto L; Palmisano L; Rivellese AA; Riccardi G; Capaldo B
    Cardiovasc Diabetol; 2020 Oct; 19(1):166. PubMed ID: 33010807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes.
    Goh YA; Lan NSR; Linn K; Wood C; Gupta A; Yeap BB; Fegan PG
    J Diabetes Complications; 2023 Aug; 37(8):108557. PubMed ID: 37473636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.
    Serés-Noriega T; Giménez M; Perea V; Boswell L; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Diabetes Care; 2022 Oct; 45(10):2412-2421. PubMed ID: 35944257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypoglycemia and hypoglycemia awareness are associated with preclinical atherosclerosis in patients with type 1 diabetes without an estimated high cardiovascular risk.
    Mesa A; Giménez M; Perea V; Serés-Noriega T; Boswell L; Blanco J; Milad C; Pané A; Esmatjes E; Vinagre I; Conget I; Viñals C; Amor AJ
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3785. PubMed ID: 38436542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes.
    Viñals C; Conget I; Pané A; Boswell L; Perea V; Blanco AJ; Ruiz S; Giménez M; Vinagre I; Esmatjes E; Ortega E; Amor AJ
    Diabetes Metab Res Rev; 2020 Oct; 36(7):e3320. PubMed ID: 32239693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population.
    Bovi TG; Zantut-Wittmann DE; Parisi MCR
    Diabetes Metab Syndr; 2019; 13(3):2322-2327. PubMed ID: 31235175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of 2019 ESC risk classification and the Steno type 1 risk engine in predicting cardiovascular events in adults with type 1 diabetes: A retrospective study.
    Tecce N; Masulli M; Palmisano L; Gianfrancesco S; Piccolo R; Pacella D; Bozzetto L; Massimino E; Della Pepa G; Lupoli R; Vaccaro O; Riccardi G; Capaldo B
    Diabetes Res Clin Pract; 2022 Aug; 190():110001. PubMed ID: 35863552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of a long-term cardiovascular disease risk prediction equation for low-incidence populations: the CAMUNI-MATISS Cohorts Collaboration study.
    Veronesi G; Gianfagna F; Giampaoli S; Chambless LE; Grassi G; Cesana G; Ferrario MM
    Eur J Prev Cardiol; 2015 Dec; 22(12):1618-25. PubMed ID: 25501263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore'.
    Novo S; Carità P; Lo Voi A; Muratori I; Tantillo R; Corrado E; Kalodiki E; Novo G
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):91-96. PubMed ID: 30557211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular or chronological age: which is the better marker to estimate the cardiovascular risk in patients with type 1 diabetes?
    de Andrade CRM; Silva ELC; da Matta MFB; Castier MB; Rosa MLG; Gomes MB
    Acta Diabetol; 2016 Dec; 53(6):925-933. PubMed ID: 27528365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study.
    Jensen MT; Sogaard P; Gustafsson I; Bech J; Hansen TF; Almdal T; Theilade S; Biering-Sørensen T; Jørgensen PG; Galatius S; Andersen HU; Rossing P
    Diabetologia; 2019 Dec; 62(12):2354-2364. PubMed ID: 31664481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
    Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
    Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014.
    Karjalainen T; Adiels M; Björck L; Cooney MT; Graham I; Perk J; Rosengren A; Söderberg S; Eliasson M
    Eur J Prev Cardiol; 2017 Jan; 24(1):103-110. PubMed ID: 27708071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
    Herath HM; Weerarathna TP; Umesha D
    Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
    Dei Cas A; Aldigeri R; Mantovani A; Masulli M; Palmisano L; Cavalot F; Bonomo K; Baroni MG; Cossu E; Cavallo G; Cimini FA; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Morieri ML; Pollis RM; Targher G; Vigili de Kreutzenberg S
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e789-e798. PubMed ID: 36881927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies.
    Bahrami HSZ; Jørgensen PG; Hove JD; Dixen U; Biering-Sørensen T; Rossing P; Jensen MT
    Eur Heart J Cardiovasc Imaging; 2023 Oct; 24(11):1555-1562. PubMed ID: 37638773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.
    Miller RG; Anderson SJ; Costacou T; Sekikawa A; Orchard TJ
    Diab Vasc Dis Res; 2016 Jul; 13(4):250-9. PubMed ID: 27190081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.